Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
2020 Analysis on PTAB Contested Proceedings
2020 Analysis on PTAB Contested Proceedings
November 24, 2020
1min
Time Is of the Essence to Avoid U.S. Trademark Fee Increases Set for 2021
Time Is of the Essence to Avoid U.S. Trademark Fee Increases Set for 2021
November 20, 2020
3min
Seeing Green – Post-Election Day 2020: State Trademarks for Cannabis Goods & Services
Seeing Green – Post-Election Day 2020: State Trademarks for Cannabis Goods & Services
November 10, 2020
5min
Recent News
David Karceski Named to Baltimore Mayor-Elect Brandon Scott’s Transition Team
David Karceski Named to Baltimore Mayor-Elect Brandon Scott’s Transition Team
December 03, 2020
1min
Venable Launches Chicago Office and Adds Construction Law Group
Venable Launches Chicago Office and Adds Construction Law Group
December 01, 2020
4min
The Venable Foundation Recognized as Platinum-Level Participant in D.C. Access to Justice's Raising the Bar Campaign
The Venable Foundation Recognized as Platinum-Level Participant in D.C. Access to Justice's Raising the Bar Campaign
November 24, 2020
3min